home dot 3

Imagine if we could improve patient outcomes by selectively eliminating the most aggressive cancer cells. Dr. Rankin and her team are working to develop novel therapies for advanced cancers. As a post-doctoral fellow, Dr. Rankin was part of the team that identified a link between the AXL signaling pathway and metastatic cancers including advanced breast, ovarian and kidney cancers.

Leave a Reply